The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Open accessAbstract
Motivation: Many drug combinations are routinely assessed to identify synergistic interactions in the attempt to develop novel treatment strategies. Appropriate software is required to analyze the results of these studies. Results: We present Combenefit, new free software tool that enables the visualization, analysis and quantification of drug combination effects in terms of synergy and/or antagonism. Data from combinations assays can be processed using classical Synergy models (Loewe, Bliss, HSA), as single experiments or in batch for High Throughput Screens. This user-friendly tool provides laboratory scientists with an easy and systematic way to analyze their data. The companion package provides bioinformaticians with critical implementations of routines enabling the processing of combination data. Availability and Implementation: Combenefit is provided as a Matlab package but also as standalone software for Windows (http://sourceforge.net/projects/combenefit/). Contact: Giovanni.DiVeroli@cruk.cam.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739
Long, G. V., Fung, C., Menzies, A. M., Pupo, G. M., Carlino, M. S., Hyman, J., Shahheydari, H., Tembe, V., Thompson, J. F., Saw, R. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6694 · Cited by 375
Systems-level antimicrobial drug and drug synergy discovery
Roemer, T., & Boone, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1205 · Cited by 159
Research works printed but not linked: 14
- Bliss, 1939, The toxicity of poisons applied jointly, Ann. Appl. Biol, 26, 585, 10.1111/j.1744-7348.1939.tb06990.x · DOI · Paper page
- Dressler, 1999, CombiTool–a new computer program for analyzing combination experiments with biologically active agents, Comput. Biomed. Res, 32, 145, 10.1006/cbmr.1999.1509 · DOI
- Greco, 1995, The search for synergy: a critical review from a response surface perspective, Pharmacol. Rev, 47, 331, 10.1016/S0031-6997(25)06847-4 · DOI · Paper page
- He, 2015, Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection, Sci. Transl. Med, 7, 1, 10.1126/scitranslmed.3010286 · DOI
- Held, 2013, Genotype-selective combination therapies for melanoma identified by high-throughput drug screening, Cancer Discov, 3, 52, 10.1158/2159-8290.CD-12-0408 · DOI
- Lehár, 2009, Synergistic drug combinations tend to improve therapeutically relevant selectivity, Nat. Biotechnol, 27, 659, 10.1038/nbt.1549 · DOI · Paper page
- Loewe, 1953, The problem of synergism and antagonism of combined drugs, ArzneimiettelForschung, 3, 286
- Loewe, 1926, Effect of combinations: mathematical basis of problem, Arch. Exp. Pathol. Pharmacol, 114, 313, 10.1007/BF01952257 · DOI · Paper page
- Mathews Griner, 2014, High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells, Proc. Natl. Acad. Sci. USA, 111, 2349, 10.1073/pnas.1311846111 · DOI · Paper page
- Odds, 2003, Synergy, antagonism, and what the chequerboard puts between them, J. Antimicrob. Chemother, 52, 1., 10.1093/jac/dkg301 · DOI · Paper page
- Prichard, 1990, A three-dimensional model to analyze drug-drug interactions, Antiviral Res, 14, 181, 10.1016/0166-3542(90)90001-N · DOI · Paper page
- Sun, 2013, High-throughput methods for combinatorial drug discovery, Sci. Trans. Med, 5, 205rv1, 10.1126/scitranslmed.3006667 · DOI · Paper page
- Tan, 2012, Systematic identification of synergistic drug pairs targeting HIV, Nat. Biotechnol, 30, 1125, 10.1038/nbt.2391 · DOI
- Webb, 1963, Effect of more than one inhibitor, Enzyme Metab. Inhib, 1, 66
Cited by
Zheng, S., Wang, W., Aldahdooh, J., Malyutina, A., Shadbahr, T., Tanoli, Z., Pessia, A., & Tang, J. (2022) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.01.004 · Cited by 733
Kinsey, C. G., Camolotto, S. A., Boespflug, A. M., Guillen, K. P., Foth, M., Truong, A., Schuman, S. S., Shea, J. E., Seipp, M. T., Yap, J. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0367-9 · Cited by 634
Sulkowski, P. L., Corso, C. D., Robinson, N. D., Scanlon, S. E., Purshouse, K. R., Bai, H., Liu, Y., Sundaram, R. K., Hegan, D. C., Fons, N. R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2463 · Cited by 555
Guillen, K. P., Fujita, M., Butterfield, A. J., Scherer, S. D., Bailey, M. H., Chu, Z., DeRose, Y. S., Zhao, L., Cortes-Sanchez, E., Yang, C.-H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00337-6 · Cited by 416
Duarte, D., & Vale, N. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100110 · Cited by 340
Metadata
- Authors
- Di Veroli, G. Y., Fornari, C., Wang, D., Mollard, S., Bramhall, J. L., Richards, F. M., & Jodrell, D. I.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-25
- Volume
- 32
- Issue
- 18
- Pages
- 2866-2868
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W2344726805
- Cited by
- 736
- References
- 3
- FWCI
- 27.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combenefit: an interactive platform for the analysis and visualization of drug combinations. https://app.cochat.ai/papers/10.1093/bioinformatics/btw230
- The paper
- Di Veroli, G. Y., Fornari, C., Wang, D., Mollard, S., Bramhall, J. L., Richards, F. M., & Jodrell, D. I. (2016). Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. https://doi.org/10.1093/bioinformatics/btw230
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.